Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy. (nature.com)

Authors: Jimenez-Vazquez S … Tschaharganeh DF Journal: Nature Communications Published: 2026-09-10 DOI: https://doi.org/10.1038/s41467-026-77465-5